tbuckley/cabot-search huggingface dataset:
P1.09-06 SRSF9 Fuels PD-1+ Regulatory T Cells and Cancer Oncogenic Pathway to Drive Hyperprogression Under Immunotherapy
Authors: Z.-Y. Dong, Z.-X. Rong, D.-D. Han, X.-T. Cai, J.-R. Lin, S.-C. Ma
Journal: Journal of Thoracic Oncology (2023)
P2.11-03 Synergistic Co-Targeting Of MYC And KRAS In Lung Cancer By Novel Ligand-Directed Inverted Chimeric RNAi Molecules
Authors: Y. Chareddy, H.P. Huggins, C. Gutierrez-Ford, S.H. Azam, J. Im, A.A. Bowers, M. Egli, C.V. Pecot
Journal: Journal of Thoracic Oncology (2023)
P1.25-09 TARGET: A Phase II Study of 5-year Adjuvant Osimertinib in Completely Resected EGFR-mutated Stage II-IIIB NSCLC
Authors: R. Soo, F. De Marinis, J.-Y. Han, C.M.J. Ho, Y. Lin, L. Servidio, M. Sandelin, S. Popat
Journal: Journal of Thoracic Oncology (2023)
EP07.01-33 Recurrence Patterns and Prognostic Factors for Relapse in Operated Lung Cancers
Authors: B. Komurcuoglu, A. Ucvet, O. Batum, M.A. Turk, S. Yazgan, M. Gayaf, B. Salik, G. Balci
Journal: Journal of Thoracic Oncology (2023)
EP02.03-07 LINC00629 Regulates Cell Proliferation, Migration, Invasion and Apoptosis of Lung Adenocarcinoma
Authors: S. He, M. Meng, S. Xing, X. Tian, L. Zhou, Y. Zhang, G. Shen, T. Zhang, E. Li, L. Zhang, Y. Bai, H. Ma
Journal: Journal of Thoracic Oncology (2023)
P2.09-03 Lazertinib vs Gefitinib in Treatment-Naïve Patients with EGFR-mutated NSCLC: LASER301 Asian Subpopulation Analysis
Authors: T. Reungwetwattana, B.C. Cho, K.H. Lee, Y.K. Pang, C.H. Fong, J.H. Kang, Y.-G. Lee, C.S. Lim, P. Danchaivijitr, Y.N. Lim, Y. Lee, S.H. How, S. Geater, S.S. Lee, Y.J. Min, J.-H. Kim, J.-S. Lee, G.-W. Lee, R.A. Soo, S. Choi, S.Y. Lee, M.-J. Ahn
Journal: Journal of Thoracic Oncology (2023)
P1.18-03 Patients with Smoking-Associated Atherosclerotic Cardiovascular Diseases: Does Prevalung Refines Eligibility for Screening?
Authors: D. Boulate, M. Fidelle, C. Caramella, J. Issard, O. Planché, P. Pradère, G. Dauriat, D. Garelik, S. Mussot, D. Mitilian, O. Hache, L. Lamrani, M. Zins, H. Beaussier, G. Chatellier, E. Fadel, L. Zitvogel, B. Besse, O. Mercier
Journal: Journal of Thoracic Oncology (2023)
P1.22-19 Determination of the Membranous Expression of cMET in Patients with Advanced NSCLC and RET Fusions
Authors: A. Marinello, M.R. Ghigna, M. Mandarano, A. Russo, A. Gazzah, K. Godefroy, D. Vasseur, S. Cotteret, J. Remon, F. Barlesi, D. Planchard, G. Metro, J.-Y. Scoazec, B. Besse, M. Aldea
Journal: Journal of Thoracic Oncology (2023)
P1.25-19 Patient-Reported Outcomes and Exercise Capacity in a Real-Life Setting in Non-small Cell Lung Cancer Patients Undergoing Radiotherapy
Authors: R. Bultijnck, L. van der Weijst, A. Van Damme, V. Huybrechts, M. van Eijkeren, Y. Lievens
Journal: Journal of Thoracic Oncology (2023)
MA05.03 Questionnaire Survey on the Experience and Awareness of Personalized Medicine in Patients with Lung Cancer
Authors: K. Hasegawa, K. Onishi, H. Aoshima, K. Nishimura, S. Iizumi, M. Hiraoka, N. Yamaguchi, Y. Kuwahara, R. Tsubouchi, T. Sawa
Journal: Journal of Thoracic Oncology (2023)
EP14.04-02 Expression of TILs and Patterns of Gene Expression from Paired Samples of Malignant Pleural Mesothelioma (MPM) Patients (p)
Authors: S. Cedres, G. Serna, A. Valdivia, J.D. Assaf, P. Iranzo, A. Callejo, N. Pardo, A. Navarro, A. Martinez-Marti, I. Priano, A. Gonzalez-Medina, R. Fasani, X. Guardia, J. Gonzalo, C. Carbonell, J. Frigola, R. Amat, A. Vivancos, P. Nuciforo, E. Felip
Journal: Journal of Thoracic Oncology (2023)
P2.16-06 A Phase 2 Study of Ifinatamab Deruxtecan (I-DXd; DS-7300) in Patients with Previously Treated ES-SCLC
Authors: C. Rudin, M. Johnson, N. Girard, C.L. Hann, M.-J. Ahn, M. Nishio, J. Godard, M. Arca, M. Qian, J. Singh, L. Paz-Ares
Journal: Journal of Thoracic Oncology (2023)
EP03.03-07 T-Cell Receptor Repertoire Profiling as a Predictive Biomarker for Immunotherapy in Unresectable Stage III Non-small Cell Lung (NSCLC)
Authors: N. Trachu, N. Iemwimangsa, D. Anantaya, P. Lumjiaktase, V.-H. Teoh, S. Oranratnachai, T. Thamrongjirapa, K. Khiewngam, N. Monnamo, P. Sanvarinda, P. Incharoen, A. Charoenyingwattana, W. Chantratita, T. Reungwetwattana
Journal: Journal of Thoracic Oncology (2023)
EP12.01-05 Osimertinib in Epidermal Growth Factor Receptor-Mutated (EGFR+) Metastatic Non-Small-Cell Lung Cancer (NSCLC) Real-World Patients
Authors: B. Távara, L. López, S. Medina, M.L. Garrido, A. López, M. López, M.E. Vallejo Pascual, P. Diz Taín
Journal: Journal of Thoracic Oncology (2023)
EP09.02-03 A Phase II Study on Aggressive Local Consolidative Therapy in Combination With Chemotherapy for Oligometastic NSCLC: TORG1529
Authors: T. Tokito, K. Yamada, H. Ishii, Y. Takiguchi, G. Saito, K. Minato, H. Imai, H. Tanaka, S. Miura, K. Watanabe, Y. Koreeda, A. Ono, N. Furuya, T. Misumi, K. Hayakawa, E. Ogo, H. Okamoto
Journal: Journal of Thoracic Oncology (2023)
P1.08-04 Delivery of ATRA and Gefitinib by Polyphenylalanine Nanosystem to Overcome EGFR-TKI Resistance in Lung Adenocarcinoma
Authors: S. Liu, H. Zhou, B. Xu, J. Deng, F. Zeng, H. Qiu
Journal: Journal of Thoracic Oncology (2023)
EP11.03-01 Real World Outcomes of Immunotherapy for Treatment of Advanced Stage NSCLC in Jordan
Authors: T. Abu Hejleh, K. AL Sawalha, S. Abdel Hafiz, S. Yaser, H. Abu Jazar, J. Khader, A. Alnsour, I. Mohamad, R. Abdel Jalil, A. Abu-shanab, A. Gharaibeh, M. Abu Shattal, A. Al-Ibraheem, H. Haddad, N. Mahmoud, S. Obeidat, K. Al-Rabi
Journal: Journal of Thoracic Oncology (2023)
P2.20-06 Does Radical Thymectomy Influence the Neurological Outcome in Patients Aged over 65 with Thymoma and Myasthenia Gravis?
Authors: F. Lococo, C. Sassorossi, G. Santoro, G. Maurizi, R. Iorio, M. Chiappetta, E. Meacci, S. Falso, E.A. Rendina, S. Margaritora
Journal: Journal of Thoracic Oncology (2023)
EP01.01-12 Binge-Watching Frequency and Tobacco Use in Adolescents: Data from “Blaam Smoke-Free Movie” Program
Authors: D. Bafunno, D. Galetta, A. Catino, A. De Leo, M.G. D'Alonzo, V. Longo, M. Montrone, S. Montagna, I. Marech, F. Pesola, P. Pizzutilo, V. Lamorgese, N. Varesano, P. Petrillo, M. Gesualdo, A. Sicolo, A. Franchini, A. Perrone, S. Vallone, C. Destro, M.V. Pacchiana, S. Novello
Journal: Journal of Thoracic Oncology (2023)
P2.02-03 Association of irAEs with the Efficacy of PACIFIC Regimen in Patients with Unresectable Stage III NSCLC: WJOG11518L/SUBMARINE
Authors: Y. Toi, K. Haratani, Y. Nakano, Y. Sato, T. Tokito, K. Nagata, T. Masuda, A. Okada, K. Kambara, T. Aoyama, E. Tabata, K. Kashiwabara, K. Murase, N. Katakami, Y. Nakamura, K. Sakai, Y. Chiba, A. Ito, K. Nishio, N. Yamamoto, K. Nakagawa, H. Hayashi
Journal: Journal of Thoracic Oncology (2023)
EP07.03-10 Effects of Preoperative Diabetes Mellitus on Postoperative Outcomes after Robotic-Assisted Video-Thoracoscopic Pulmonary Lobectomy
Authors: C. Dalby, C.C. Moodie, J.R. Garrett, J.R. Tew, J.J. Baldonado, J.P. Fontaine, E.M. Toloza
Journal: Journal of Thoracic Oncology (2023)
P1.18-05 Te Oranga Pūkahukahu: Developing an Indigenous Māori Led Approach to Lung Cancer Screening
Authors: K. Parker, K. Bartholomew, T. Schaapveld, G. Steel, A. Fraser, B. Davis, D. Enoka, P. Sandiford, C. Lewis, D. Milne, M. McKeage, R.M. Jansen, K. Fong, H. Marshall, M. Tammemagi, S. Crengle
Journal: Journal of Thoracic Oncology (2023)
P1.20-05 Leveraging NLP to Identify Biomarker-Eligible Patients
Authors: J.C. Ruckdeschel, M.J. Edelman, M. Riley, E. Ross, S. Parthasarathy, D. Mangold, S. Taylor, R. Chamarthi, C. Rajagopal, H.-S. Hsu, G.E. Chen, C. Driscoll
Journal: Journal of Thoracic Oncology (2023)
P2.17-06 Efficacy of Platinum after Lurbinectedin + DOX or Topotecan/CAV in Sensitive Relapsed SCLC Patients in the ATLANTIS Trial
Authors: A. Navarro, E. Smit, E. Carcereny, V. Gutierrez, D. Mavroudis, N. Reinmuth, F. Bustin, J.A. Lopez-Vilariño, J. Gómez, C. Kahatt, A. Zeaiter, S. Cousin, T.E. Ciuleanu, D. Lungulescu, B. Robev, L. Paz-Ares
Journal: Journal of Thoracic Oncology (2023)
EP07.05-04 CDDP/TS1 Followed by Maintenance TS1 as Adjuvant Chemotherapy in Completely Resected Stage II-IIIA Non-Small Cell Lung Cancer
Authors: K. Fujino, R. Maruyama, K. Yoshimoto, T. Marutsuka, M. Sato, K. Iwatani, F. Tanaka, M. Suzuki
Journal: Journal of Thoracic Oncology (2023)
EP07.01-18 Adjuvant Chemotherapy is Less Effective in Non Small Cell Lung Cancer Patients Rated Undernourished by CONUT Score
Authors: K. Onodera, H. Notsuda, T. Watanabe, Y. Watanabe, T. Suzuki, H. Oishi, H. Niikawa, M. Noda, Y. Okada
Journal: Journal of Thoracic Oncology (2023)
P1.27-03 Neoadjuvant PD-1 Blockade Plus Platinum-based Chemotherapy for EGFR-mutant NSCLC (CTONG2104): An Interim Analysis
Authors: C. Zhang, D.-C. Yi, Y.-X. Sun, B.-Y. Jiang, L.-X. Yan, L.-S. Peng, S.-Y. Liu, J. Yang, H. Sun, D. Peng, Y.-S. Li, S.-A. Chen, R.-Q. Liao, X.-N. Yang, Q. Zhou, Y.-L. Wu, Z.-M. Zhang, W.-Z. Zhong
Journal: Journal of Thoracic Oncology (2023)
EP12.01-50 Real-World Characteristics and Outcomes of ERBB2-Mutant Non-small Cell Lung Cancer in Latin America Patients
Authors: E. Saldanha, V.C.C. De Lima, M. Corassa, O. Arrieta, A. Fares, L. Gil Santana, J.A. Soler, D. Chamorro, J. Rodríguez, H. Freitas, A.F. Cardona
Journal: Journal of Thoracic Oncology (2023)
P1.25-15 Trends and Disparities in Curative-Intent Treatment for Early-Stage Non-Small Cell Lung Cancer: A Population-Based Analysis of Surgery and SBRT
Authors: Q. Liu, H.N. Medina, K.T. Jacobs, C.P. Brown, T. Koru-Sengul, G. De Lima Lopes, E. Rodriguez, P. Pinheiro
Journal: Journal of Thoracic Oncology (2023)
EP10.01-06 Predictors of Survival for Docetaxel as a Subsequent Line after Progression to Platinum-Based Chemotherapy and Immunotherapy
Authors: Y. Garitaonaindía Díaz, V. Calvo de Juan, M. Uribarren, I. Redondo Canovas del Castillo, A. Collazo Lorduy, A.V. Ospina, M. Blanco Clemente, C. Lozano, M. Manso, M. Martinez Cutillas, C. Traseira, J.C. Sanchez Gonzalez, B. Nunez Garcia, M. Provencio
Journal: Journal of Thoracic Oncology (2023)
EP03.06-01 Differential Anticancer Compound Response of Filipino Patient-derived Lung Adenocarcinoma Cells (GL01) Against A549 Cell Line
Authors: K.C.J. Fernandez, P.G. Moreno, D. Macapagal, M. Cabanatan, R. Nacario, G. Completo, M.T. Barzaga, N. Tan-Liu, F.M. Heralde
Journal: Journal of Thoracic Oncology (2023)
P1.25-01 Real-World Data of Completely Resected Lung Adenocarcinoma Harboring Common EGFR Mutation in Japan (CReGYT-01 EGFR study)
Authors: S. Katsumata, A. Hamada, N. Haratake, S. Takamori, Y. Takanashi, K. Hayasaka, K. Nomura, M. Toda, T. Kaiho, H. Hoshino, H. Ozawa, S. Matsuo, J. Suzuki, K. Nakahashi, K. Fujino, K. Takegahara, I. Kinoshita, K. Takada, M. Yoshikawa, Y. Tomioka, Y. Koki, M. Shimokawa, J. Soh, S. Shiono, Y. Ohde
Journal: Journal of Thoracic Oncology (2023)
P2.11-05 SHERLOCK: Phase II Trial of Upfront Sotorasib with Chemotherapy and Bevacizumab for Advanced NSCLC with KRASG12C Mutation
Authors: C. Lee, N. Pavlakis, D.D.-X. Zhou, C. Brown, B.G.M. Hughes, S. Yip, V.J. Bray, F.T. Daley, R. Roberts-Thomson, M.M. Cummins, T. John, B.J. Solomon, P. Mitchell
Journal: Journal of Thoracic Oncology (2023)
P1.15-03 Dedicated Cardiovascular Screening in Lung Cancer Screening: Preliminary Results from the European 4-IN-THE-LUNG-RUN Trial
Authors: M. Vonder, C. van der Aalst, J. Hubert, D. Moldovanu, A. Schmitz, J.W.C. Gratama, M. Silva, H. de Koning, M. Oudkerk
Journal: Journal of Thoracic Oncology (2023)
EP17.04-07 Lung Stereotactic Body Radiation Therapy in a Developing Country: Patterns of Safety and Treatment Toxicities
Authors: R.A. Bart Aguiar, R. Ferrari de Sa, L. de Oliveira Franco, E. Fuks, P.C. Ventura Canary, C.E. Veloso de Almeida, D. Przybysz
Journal: Journal of Thoracic Oncology (2023)
EP12.02-03 Judith Tam ALK Lung Cancer Research Initiative
Authors: L.E. Goo, V.G. Kathawate, N. Merrill, A. Udager, P. Hsu, J. Spence, M. Soellner, S. Nagrath, K. Lagisetty, M.E. Aikins, P. Ulintz, D. Nancarrow, N. Henderson, X. Cheng, L. Bao, M. Slayton, N. Busette, H. Serhan, C.-J. Liu, Z. Farah, Y. Lee, M. Downey, R. Sexton, Y. Chen, S. Fouladdel, L. Tudrick, Z. Qin, H. Ball, B. Vandenburg, S. Fry, A. Qin, S.D. Merajver
Journal: Journal of Thoracic Oncology (2023)
P2.16-05 Durvalumab+EP in Advanced Large-Cell Neuroendocrine Carcinoma of Lung (aLCNEC): a Pilot Phase II study
Authors: E. Dudnik, L. Ariel, K. Hod, H. Nechushtan, E. Hanovich, O. Rotem, M. Wollner, M. Guindy, M.A. Ben David
Journal: Journal of Thoracic Oncology (2023)
P2.18-02 Successful Generation of Tumor-Infiltrating Lymphocytes (TIL) for Adoptive Cell Therapy from Mesothelioma
Authors: D.A. Fennell, C. Poile, A. Bzura, J. Dzialo, A. Nakas, K. Kutywayo, A. Natarajan, C. Herman, R. Kovatch, B. Bunch, A. Veerapathran
Journal: Journal of Thoracic Oncology (2023)
P1.03-02 Combinationof Anlotinib and Tislelizumab for Lung Adenocarcinoma: Effects on Metabolic and Flora Microenvironment
Authors: Y. Nie, Z. Yang, G. Yao, X. Xu, Y. Zhao, K. Yin, W. Zhang, Q. Li, F. zhou
Journal: Journal of Thoracic Oncology (2023)
MA01.06 Retrospective Analysis of Intrapleural Administration of Hypotonic Cisplatin for Malignant Pleural Effusions with Non-Expandable Lung
Authors: W. Mori, T. Mimori, Y. Masui, J. Ito, T. Miyawaki, T. Shukuya, K. Takahashi
Journal: Journal of Thoracic Oncology (2023)
EP03.03-04 Decoding the Immune Dysfunction of Cancer Cachexia in Lung Cancer Patients
Authors: L.C. Roisman, S. Abo-Zaid, A. Anoze, W. Kian, I. Massalha, F. Argaman, W. Shalata, B. Kraym, M. Awad, D. Levitas, N. Peled
Journal: Journal of Thoracic Oncology (2023)
P1.14-04 European Lung Cancer Screening Implementation: 4-IN-THE-LUNG-RUN trial
Authors: C. van der Aalst, M. Vonder, J. Hubert, D. Moldovanu, A. Schmitz, S. Delorme, R. Kaaks, K. ten Haaf, M. Oudkerk, H. de Koning
Journal: Journal of Thoracic Oncology (2023)
MA12.11 A Novel 89Zr-anti-PD1 immunoPET-CT May Predict Response to PD-1 Inhibitors in a Lung Cancer Murine Model Receiving Immunotherapy
Authors: A. Puyalto, M. Rodríguez-Remírez, I. López, J.A. Simón, M. Ecay, M. Collantes, A. Vilalta-Lacarra, A. Francisco-Cruz, J.L. Solórzano, I. Peñuelas, D. Ajona, I. Gil-Bazo
Journal: Journal of Thoracic Oncology (2023)
P2.09-01 A Large Asian Real-World EGFR exon 20Insertion Mutated NSCLC Dataset with Deep Genomic Characterization
Authors: A.C. Tan, G.G.Y. Lai, S.P.L. Saw, M. Pang, J.C. Yeo, J. Alvarez, A.J. Skanderup, K.H. Lim, A. Takano, G.S. Tan, W.C. Tan, J.W.K. Chan, Y.L. Teh, T. Rajasekaran, A. Jain, W.L. Tan, Q.S. Ng, R. Kanesvaran, W.T. Lim, E.H. Tan, M.K. Ang, D.S.W. Tan
Journal: Journal of Thoracic Oncology (2023)
P1.22-13 Predominant Solid Patterns in Advanced EGFR Mutated Lung Adenocarcinoma Treated with TKI Is Associated with Worse Outcomes
Authors: D. Heredia, D. Davila-Dupont, A. Aviles, H. Williams, A. Regino, C. Delgado, D. Bazo, O. Arrieta
Journal: Journal of Thoracic Oncology (2023)
P2.17-03 CAN: A Phase II Trial of Combination of Niraparib and Anlotinib in Patients with Recurrent Small Cell Lung Cancer
Authors: Y. Cheng, Y. Liu, Y. Xin, J. Zhu, H. Cui, L. Zhang, Y. Wang, Q. Zhang, H. Wei
Journal: Journal of Thoracic Oncology (2023)
P2.05-01 Clinical impact of TTF-1 for Combined Chemoimmunotherapy Efficacy in Lung Adenocarcinoma: A Multicenter Prospective Study
Authors: Y. Katayama, T. Yamada, K. Morimoto, T. Takeda, A. Okada, S. Shiotsu, Y. Chihara, O. Hiranuma, T. Yamada, T. Ota, T. Harada, I. Hasegawa, K. Takayama
Journal: Journal of Thoracic Oncology (2023)
P2.09-30 Enhanced in Vivo Efficacy of Mobocertinib and Amivantamab Combination in EGFR ex20ins+ NSCLC PDX Models
Authors: S. Chatterjee, X. Le, M. Nilsson, M. Smith, A. Barakat, I. Celen, E.N. Churchill, H. Udagawa, A. Poteete, A.N. Pfeil, J.V. Heymach, S. Vincent
Journal: Journal of Thoracic Oncology (2023)
P2.07-01 Development of Postoperative Bronchopleural Fistula after Neoadjuvant Immunochemotherapy in Non-small Cell Lung Cancer: Case Reports
Authors: K. Ma, X. Wang, S.r. Zhao, C. Sun, H.y. Xu, P. Zhang, P.y. Liu, Y.x. Lin, S. Qiu, Y. Guo, G.z. Yang, G.g. Shao
Journal: Journal of Thoracic Oncology (2023)
EP08.02-06 Neoadjuvant Therapy, Still a Contraindication to VATS Lobectomy or is it a New Indication?
Authors: T.E. Sevinç, H. Melek, E. Suleymanov, G. Gedikoglu-Pirim, A.S. Bayram, C. Gebitekin
Journal: Journal of Thoracic Oncology (2023)
P2.12-08 Response to Emerging Targeted Therapies and Genomic Analysis for NSCLC with Leptomeningeal Metastases and Uncommon Mutations
Authors: G.-L. Jie, M.-M. Zheng, H.-Y. Tu, K. Yin, Q. Zhou, J.-J. Yang, X.-C. Zhang, B.-C. Wang, H.-J. Chen, B.-Y. Jiang, Y.-S. Li, Y.-L. Wu
Journal: Journal of Thoracic Oncology (2023)
P2.31-12 Sexual Dysfunction on Patients with Lung Cancer: Results from the CLARIFY Project
Authors: A.V. Ospina Serrano, V. Calvo, A. Collazo-Lorduy, M. Blanco, I. Triana, M. Torrente, C. Parejo, P. Martinez, M. Provencio-Pulla
Journal: Journal of Thoracic Oncology (2023)
EP14.04-01 BRCA-Associated Protein-1 (BAP1) Loss and Real-World Outcomes of Immune Checkpoint Inhibitor Therapy in Pleural Mesothelioma
Authors: C.J. Smith, A. Desai, A. Hazim, A. Dimou, K. Leventakos, J. Molina, K. Parikh, A. Kommalapati, C. Hocum, J.N. Moffett, A. Schwecke, A.S. Mansfield
Journal: Journal of Thoracic Oncology (2023)
EP03.03-08 Single-nucleus RNA Sequencing Dissecting the Tumor Microenvironment of Liver Metastasis of Non-small Cell Lung Cancer
Authors: J. Huang, X. Chen, J. Shen, L. Zhu, J. Liang, K. Wu, S. Yang, B. Xia, S. Ma
Journal: Journal of Thoracic Oncology (2023)
P2.06-01 Cemiplimab-Based Treatment in Advanced NSCLC With Liver Metastases: Updated Analysis From EMPOWER-Lung 1 and EMPOWER-Lung 3
Authors: A. Baramidze, C. Gessner, M. Gogishvili, A. Sezer, T. Makharadze, S. Kilickap, M. Gumus, Y. Li, S. Li, M. Salvati, J.-F. Pouliot, F. Seebach, I. Lowy, G. Gullo, P. Rietschel
Journal: Journal of Thoracic Oncology (2023)
EP07.02-08 Comparison of ICG and Methylene Blue in Preoperative Dye Marking Localization of Pulmonary Nodules Under the Guidance of ENB
Authors: Y.-B. Lin, H. Yang, K.-J. Luo, X.-D. Lin, G.-M. Wang, J.-W. Xie, H. Yang, Z.-R. Zhao, X-d. Su, Y. Hu, L.-J. Zhang
Journal: Journal of Thoracic Oncology (2023)
EP07.01-05 A Study of the Characteristics of Lung Cancer Surgery Cases in the Elderly and the Usefulness of the Japanese NCD risk calculator
Authors: T. Kawaguchi, F. Watanabe, K. Adachi, H. Kuru, H. Tarumi, C. Tsuji, S. Iwanaka, Y. Sakakura, T. Nishimura, M. Naito, H. Ibata
Journal: Journal of Thoracic Oncology (2023)
P2.09-41 Phase I/II Study Exploring Safety and Efficacy of Apl-101 Plus Frontline Osimertinib in EGFR-mutated Metastatic Non-small Cell Lung Cancer
Authors: B. Patel, N. Wu, S. Myles, D. Turlington, P. Yu, G. Saha, A. Rohatgi, B.H. Herzog, J.P. Ward, M.Q. Baggstrom, S.N. Waqar, D. Morgensztern, R. Govindan, S. Devarakonda
Journal: Journal of Thoracic Oncology (2023)
P1.16-05 Quality Initiative to Improve Timeliness of Care in a Rapid Assessment Lung Cancer Clinic
Authors: S.V. Dabholkar, S.K. Vinod, V. Bray, Z. Harrington, P. Collett, B. Kolevski, B. Ivimey, J. Descallar, J. Williamson
Journal: Journal of Thoracic Oncology (2023)
OA15.04 Comparison of Digital Vs Manual PD-L1 Tumour Cell Scoring on SP263-Stained Whole Imaging Slides from IMpower110
Authors: R.S. Herbst, D. Ruderman, J. Conway, H. Prizant, S. Hennek, J. Shamshoian, J. Abel, M. Montalto, A. Beck, I. Wapinski, L. Molinero, R. Amin, T. Hoang, M. Ballinger, F. de Marinis, G. Giaccone, J. Jassem, J. Giltnane, M.K. Srivastava, D.R. Spigel
Journal: Journal of Thoracic Oncology (2023)
MA20.06 Association of TTF-1 Expression with Outcomes to Immunotherapy and KRAS G12C Inhibition in Lung Adenocarcinoma
Authors: A. Di Federico, B. Ricciuti, J.V.M. Alessi, F. Pecci, G. Lamberti, M.M. Gandhi, V. Vaz, E. Voligny, T. Nguyen, D. Haradon, L.M. Sholl, M. Nishino, A.J. Cooper, S. Digumarthy, P.A. Janne, R.S. Heist, B.E. Johnson, J. Luo, M.M. Awad
Journal: Journal of Thoracic Oncology (2023)
P2.12-07 Phase II Trial of LP-300 + Pemetrexed/Carboplatin in Patients Who Never Smoked with Lung Adenocarcinoma After TKI Progression
Authors: J. Treat, N. Abdulla, B. Bank, R. Zuniga, K. Konduri, N. Gabrail, R. Ewesuedo, K. Bhatia, J.N. Bodor, Y. Goto
Journal: Journal of Thoracic Oncology (2023)
EP12.01-46 L858R Exon 21 Mutation Is Associated with a Higher Risk of Brain Metastases in Patients with NSCLC Treated with TKI
Authors: H. Bravo, D. Heredia, C. Izquierdo, A. Regino, N. Lozano, A. Solis, O. Arrieta
Journal: Journal of Thoracic Oncology (2023)
P2.06-07 PD-L1 Expression Guidance on Sintilimab versus Pembrolizumab in Untreated Advanced NSCLC (CTONG1901)
Authors: S.-Y.M. Liu, J.-Y. Deng, H.-H. Yan, M.-Y. Yang, C.-R. Xu, M.-Y. Zheng, B. Gan, X.-C. Zhang, H.-Y. Tu, J.-J. Yang, H.-J. Chen, B.-C. Wang, Y. Li, Q. Zhou, Y.-L. Wu
Journal: Journal of Thoracic Oncology (2023)
P2.22-02 Long-term Survival in Patients with Primitive Neuroectodermal Tumors of Thorax: Does Size Matter?
Authors: I. Sarbay, A. Aygun, A. Turna, H. Turna, S. Derin, A. Demir, N. Molinas Mandel, K. Kaynak
Journal: Journal of Thoracic Oncology (2023)
EP07.04-30 Analysis of Radiologic-Pathologic Correlation for Subsolid Lung Adenocarcinoma Using the Whole-Mount Section Technique: A Prospective Study
Authors: T. Ye, X. Shen, S. Wang, H. Wu, H. Hu, Y. Zhang, Q. Huang, Z. Wang, Y. Gu, Y. Li, H. Chen, C. Deng
Journal: Journal of Thoracic Oncology (2023)
EP10.01-17 Treatment Patterns and Clinical Outcomes among Advanced NSCLC Patients with EGFR exon 20 Insertion Mutations in China
Authors: Y. Wang, H.M. Lin, N. Ning, F. Du, X. Gao, Q. Dong, G. Yang, H. Xu, Y. He, C. Zhou
Journal: Journal of Thoracic Oncology (2023)
P1.12-04 In Vivo Efficacy of AZD9592, an EGFR-cMET Bispecific ADC, in a Broad Panel of NSCLC Patient-Derived Xenograft Models
Authors: L. McGrath, E. Rosfjord, S. Christ, Y. Zheng, N. Floch, C.C. Sachs, C. Cotoi, S. Batelli, E. Cantu, S. Makaretz, I. Grenga, F. Arnaldez, F. Comer
Journal: Journal of Thoracic Oncology (2023)
EP12.02-09 Prevalence and Treatment of Advanced NSCLC patients with REarranged During Transfection [RET]-fusion at a South Korean Centre
Authors: S. Yoon, K.-P. Kim, G. Segall, A.R. Jeon, M.H. Jen, S.R. Kim, J.M. Cho, X. Zhao, J. Kim, K.C. Toh, D.H. Lee
Journal: Journal of Thoracic Oncology (2023)
P1.26-09 Wedge Resection vs. Segmentectomy for NSCLC Size ≤2 CM, Consolidation Tumor Ratio &gt;0.25, cN0: A Multicenter Propensity-Score Matching Analysis
Authors: T. Isaka, H. Adachi, K. Murakam, J. Miura, N. Kikunishi, N. Shigeta, Y. Kudo, Y. Miyata, M. Okada, N. Ikeda, H. Ito
Journal: Journal of Thoracic Oncology (2023)
P2.09-20 Updated Data of Osimertinib Rechallenge after Pneumonitis; A Multicenter Retrospective Cohort Study
Authors: M. Imaji, D. Fujimoto, Y. Sato, Y. Sakata, T. Yamaguchi, M. Tamiya, H. Suzuki, H. Ikeda, A. Hino, T. Kijima, H. Matsumoto, J. Uchida, M. Inaba, Y. Tsukita, D. Arai, H. Maruyama, S. Hara, S. Tsumura, T. Yokoyama, H. Sumikawa, S. Sakata, N. Yamamoto
Journal: Journal of Thoracic Oncology (2023)
P1.25-17 Stereotactic Ablative Body Radiotherapy for Early NSCLC: Changes in Pulmonary Function, Dyspnoea and Quality of Life
Authors: J. Ahn, H. Gee, S. Vinod, P.H. Graham, R. Yeghiaian-Alvandi, Y. Chin, J. Ludbrook, F. Hegi-Johnson, A. Last, P. Dwyer, A. Ong, L.H. Browne, N. Aherne, M. Azzi, X. Ma, E. Hau
Journal: Journal of Thoracic Oncology (2023)
P1.25-16 Outcomes by Age with Neoadjuvant Atezolizumab Treatment for Resectable Non-small Cell Lung Cancer in the Phase 2 LCMC3 Study
Authors: C. Presley, D.H. Owen, A. Nicholas, S. Hilz, F. Oezkan, J.E. Chaft, E.M. Toloza, E.B. Haura, A. Patterson, S.N. Waqar, P. Bunn, B.E. Johnson, M.G. Kris, J.M. Lee, D.J. Kwiatkowski, I.I. Wistuba, K. Schulze, A. Johnson, V.W. Rusch, D.P. Carbone
Journal: Journal of Thoracic Oncology (2023)
P1.08-01 CoxMoE: A Deep Learning Model Predicts Survival and Response in T790M Positive NSCLC Patients Treated with Third-Generation EGFR-TKI
Authors: N. Lou, X. Cui, X. Lin, R. Gao, C. Xu, N. Qiao, J. Jiang, L. Wang, W. Wang, S. Wang, W. Shen, X. Zheng, P. Hu
Journal: Journal of Thoracic Oncology (2023)
EP06.02-01 Prevalence of PD-L1 Expression in Non-Small Cell Lung Cancer: a Real-World Australian Perspective
Authors: S. Prabhakaran, P.A. Russell, A.L. Farrall, K. Asadi, W. Barrett, C. Cooper, W. Cooper, E.E. Duhig, M. Egan, S. Fox, D. Godbolt, S. Gupta, S. Cotton, C. Leslie, T. Leong, D. Moffat, M. Qiu, V. Sivasubramaniam, C. Snell, J. Skerman, M. Walsh, K. Whale, S. Klebe
Journal: Journal of Thoracic Oncology (2023)